During the past decade, UCSD Division of Dermatology conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 9 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 9 clinical trials were completed. i.e. 900% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UCSD Division of Dermatology" #1 collaborator was "Galderma R&D" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "UCSD Division of Dermatology" are "Atopic Dermatitis" (5 trials), "Eczema" (2 trials), "Acne" (1 trials), "Atopic Dermatitis Eczema" (1 trials) and "Dermatitis, Atopic" (1 trials). Many other conditions were trialed in "UCSD Division of Dermatology" in a lesser frequency.

Most popular intervention types in "UCSD Division of Dermatology" are "Drug" (7 trials), "Other" (4 trials), "Biological" (3 trials), "Combination Product" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abrocitinib 200 mg" (2 trials), "Normal Saline" (2 trials), "Placebo" (2 trials), "Abrocitinib 100 mg" (1 trials) and "Autologous Microbial Transplant" (1 trials). Other intervention names were less common.

The vast majority of trials in "UCSD Division of Dermatology" are 13 trials for "All" genders.

Currently, there are NaN active trials in "UCSD Division of Dermatology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in UCSD Division of Dermatology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in UCSD Division of Dermatology, 5 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".